Bionic Reporter

Not what I remember

September 18th, 2013

Below is a Vine video of lunchtime in the courtyard of the Cleveland Clinic. Wednesday happens to be the day they host a farmer's market accompanied by a steel drum band on this day.

This place is huge. The first building you see is the Crile Building, a 12-floor facility "dedicated to outpatient care and procedures for nearly every disease or condition in every medical specialty." This building is a hospital in and of itself and wasn't even built when I first started getting treatment in 1985. Today, it's one of the smallest building on the campus.

And this Vine only shows about a quarter of the campus. This place is like LAX or O'Hare, if every one of their plane terminals had 12 to 20 floors of expert medical care facilities. There are pharmacies, laboratories, dining commons, chapels, banks, and even an InterContinental Hotel on the premises -- pretty much anything a visiting patient could need (with the exception of "people mover" walkways, although there are wheelchairs and golf carts driven by staff that are available to assist patients get around the place).

Here's a map of the Clinic, see the Crile Building (denoted with the "A" in blue near the center right of the image):

Screen Shot 2013-09-18 at 5.32.32 PM

Size aside, I have to say that every single person we met today, from the greeter, to the intake receptionist, the nurses and especially the doctors, was extremely pleasant, friendly and helpful. Which is all good, considering I'll probably be spending a lot of time here over the next few months.

And in case you needed more convincing from me that this is the place to go for any and all ailments, we heard this news on the radio on the way in this morning: The Clinic is at the forefront of marketing a vaccine to prevent breast cancer.

From a report by WKYC-TV in Cleveland:

Cleveland Clinic Innovations has created a spin-off company to develop a preventive breast cancer vaccine based on research from Cleveland Clinic's Lerner Research Institute.

The new company, Shield Biotech, will complete preclinical development and seek permission from the FDA to test the vaccine as an investigational new drug in proof-of-concept, first-in-human clinical trials.

See the full story here.

Leave a Reply

By participating in online discussions you acknowledge that you have agreed to the Star-Advertiser's TERMS OF SERVICE. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. Because only subscribers are allowed to comment, we have your personal information and are able to contact you. If your comments are inappropriate, you may be banned from posting. To report comments that you believe do not follow our guidelines, email